← All Alx Oncology Holdings INC filings

Alx Oncology Holdings INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
ALXO
Alx Oncology Holdings INC
DEF: ALX Oncology 2026 Annual Meeting Proxy Statement
ALX Oncology Holdings Inc. has scheduled its 2026 Annual Meeting of Stockholders for June 10, 2026, to conduct routine governance and compensation votes.
NASDAQ
ALXO
Alx Oncology Holdings INC
DEF: ALX Oncology Holdings Inc. Announces Details for 2025 Annual Stockholders Meeting
ALX Oncology Holdings Inc. will hold its 2025 Annual Meeting of Stockholders virtually on June 11, 2025, to elect directors, conduct an advisory vote on executive compensation, and ratify the appointment of KPMG LLP as its independent accounting firm.
NASDAQ
ALXO
Alx Oncology Holdings INC
DEFA14A: ALX Oncology Announces Board Member Resignations and Committee Changes
ALX Oncology Holdings Inc. reports the resignations of two board members and subsequent adjustments to board committees and director classifications.
NASDAQ
ALXO
Alx Oncology Holdings INC
DEF 14A: ALX Oncology Holdings Inc. Sets Date for 2024 Annual Stockholder Meeting
ALX Oncology Holdings Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 12, 2024, to vote on director elections, executive compensation, and the ratification of the company's independent auditor.